Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-07-10
2007-07-10
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210, C435S007920, C436S501000, C530S397000, C530S399000
Reexamination Certificate
active
10225503
ABSTRACT:
Methods and kits are provided for assessing the ovarian reserve and predicting the ovarian response to fertility treatments in a female subject. The serum levels of MIS are shown to be positively correlated with the production and retrieval of mature oocytes and serve as prognostic indicators for the female response to fertility treatment. The MIS levels can be monitored prior to and during fertility treatment and are useful to adjust the timing and dosage of treatments in order to produce optimal outcome in individual patients, to avoid ovarian hyperstimulation, or to indicate cancellation of an unsuccessful treatment. MIS can also be administered to women to stimulate follicle development and to prevent depletion of ovarian reserve.
REFERENCES:
patent: 4792601 (1988-12-01), Donahoe et al.
patent: 5310880 (1994-05-01), Donahoe et al.
patent: 5547854 (1996-08-01), Donahoe et al.
Fallat et al. Fertility and Sterility, vol. 67, No. 5, May 1997, pp. 962-965.
Khamsi et al. Endocrine, Aug/ 1998, vol. 9, No. 1, pp. 15-25.
Donahoe PK, Mullerian inhibiting substance in reproduction and cancer. Molecular Reproduction and Development, 1992, vol. 32, No. 2, pp. 168-172.
Donahoe (Molecular Reproduction and Development, 1992, vol. 32, No. 2, pp. 168-172) Full Document.
Coskun et al. (Journal of assisted reproduction and genetics, Jul. 1998, vol. 15, No. 6, pp. 372-377, Abstract Only).
Pellicer et al. (Journal of in vitro fertilization and embryo transfer. IVF, Aug. 1987, vol. 4, No. 4, pp. 205-217).
van Rooij, I.A. et al.,Serum Anti-Müllerian Hormone Levels: A Novel Measure of Ovarian Reserve, Human Reproduction, vol. 17, No. 12, pp. 3065-3071 (2002).
Fanchi, Renato et al., “Serum Anti-Müerian Hormone Dynamics During Controlled Ovarian Hyperstimulation,”Human Reproduction, vol. 18, No. 2, pp. 328-332, 2003.
de Vet, Annemarie et al.,Antimüllerian Hormone Serum Levels: A Putative Marker for Ovarian Aging, Fertility and Sterility, vol. 77, No. 2, pp. 357-362 (2002).
McGee, Elizabeth A. et al.,Müerian Inhibitory Substance Induces Growth of Rat Preantral Ovarian Follicles, Biology of Reproduction, vol. 64, pp. 293-298 (2001).
Seifer, David B. et al.,Early Follicular Serum Müllerian-Inhibiting Substance Levels are Associated with Ovarian Response During Assisted Reproductive Technology Cycles, Fertility and Sterility, vol. 77, No. 3, pp. 468-471 (2002).
Cook, Christine L. et al.,Serum Müllerian-Inhibiting Substance Levels During Normal Menstrual Cycles, Fertility and Sterility, vol. 73, No. 4, pp. 859-861 (2000).
Seifer, David B. et al.,Mitochondrial Deletions in Luteinized Granulosa Cells as a Function of Age in Women Undergoing In Vitro Fertilization, Fertility and Sterility, vol. 78, No. 5, pp. 1046-1048 (2000).
Sharara, Fady I. et al.,The Detection of Diminished Ovarian Reserve in Infertile Women, Am. Journal of Obstertrics and Gynecology, vol. 179, No. 3, pp. 804-812 (1998).
Vigier, Bernard et al.,Production of Anti-Müllerian Hormone: Another Homology Between Sertoli and Granulosa Cells, Endocrinology, vol. 114, No. 4, pp. 1315-1320 (1984).
Takahashi, Masahiko et al.,The Ontogeny of Mullerian Inhibiting Substance in Granulosa Cells of the Bovine Ovarian Follicle, Biology of Reproduction, vol. 35, pp. 447-453 (1986).
Bezard J., et al.,Immunocytochemical Study of Anti-Müllerian Hormone in Sheep Ovarian Follicles During Fetal and Post-Natal Development, Journals of Reproduction & Fertility, vol. 80, pp. 509-516, (1987), Great Britain.
Meyts, Rajpert-De et al.,Expression of Anti-Müllerian Hormone During Normal and Pathological Gonadal Development: Association with Differentiation of Sertoli and Granulosa Cells, Journal of Clinical Endocrinology & Metabolism, vol. 84, No. 10, pp. 3836-3844, (1999).
Hudson, Peter L. et al.,An Immunoassay to Detect Human Mullerian Inhibiting Substance in Males and Females During Normal Development, Journal of Clinical Endocrinology & Metabolism, vol. 70, No. 1, pp. 16-22, (1990).
Jusso, Nathalie et al.,An Enzyme Linked Immunoassay for Anti-Müllerian Hormone: A New Tool for the Evaluation of Testicular Function in Infants and Children, Journal of Clinical Endocrinology & Metabolism, vol. 70, No. 1, pp. 23-27 (1990).
di Clemente, Nathalie et al.,Cloning, Expression, and Alternative Splicing of the Receptor for Anti-Müllerian Hormone, Molecular Endocrinology, vol. 8, No. 8, pp. 1006-1020 (1995).
Baarends, Willy M. et al.,Anti-Müllerian Hormone and Anti-Müllerian Hormone Type II Receptor Messenger Ribonucleic Acid Expression in Rat Ovaries During Postnatal Development, the Estrous Cycle, and Gonadotropin-Induced Follicle Growth, Endocrinology, vol. 136, No. 11, pp. 4951-4962 (1995).
Teixeira, Jose et al.,Developement Expression of a Candidate Müllerian Inhibiting Substance Type II Receptor, Endocrinology, vol. 137, No. 1, pp. 160-165 (1996).
Kim, J. H. et al.,The Inhibitory Effects of Müllerian-Inhibiting Substance on Epidermal Growth Factor Induced Proliferation and Progesterone Production of Human Granulosa-Luteal Cells, Journal of Clinical Endocrinology & Metabolism, vol. 75, No. 3, pp. 911-917 (1992).
Seifer, David B. et al.,Gonadotropin-Releasing Hormone Agonist-Induced Differences in Granulosa Cell Cycle Kinetics Are Associated With Alternations in Follicular Fluid Müllerian-Inhbiting Substance and Androgen Content, Journal of Clinical Endocrinology & Metabolism, vol. 76, No. 3, pp. 711-714 (1993).
Durlinger, Alexandra L. et al.,Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary, Endocrinology, vol. 140, No. 12, pp. 5789-5796 (1999).
Lee, Mary M. et al.,Mullerian Inhibiting Substance in Humans: Normal Levels from Infancy to Adulthood, vol. 82, No. 2, pp. 571-576 (1996).
Takahashi, Masahiko et al.,Müllerian Inhibiting Substances as Oocyte Meiosis Inhibitor, Molecular and Cellular Endocrinology, vol. 47, pp. 225-234 (1986).
Cate et al, Isolation of the bovine and human genes for mullerian inhibiting substance and expression of the human gene in animal cells, Cell; 1986; 45:685-689 ABSTRACT only.
Hirshfield A N, Relationship between the Supply of primordial Follicles and the Onset of Follicular Growth in Rats, Biol Reprod 1994; 50: 421-428.
Lee and Donahoe, Mullerian Inhibiting Substance: A Gonadal Hormone with Multiple Functions, Endocrine Reviews 1993; 14(5): 152-164.
MacLaughlin David T.
Seifer David B.
Cook Lisa V.
Le Long V.
Maurer Barbara V.
The General Hospital Corporation
University of Medicine and Dentistry of New Jersey
LandOfFree
Mullerian inhibiting substance levels and ovarian response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mullerian inhibiting substance levels and ovarian response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mullerian inhibiting substance levels and ovarian response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3752461